The Fos oncogene gene family is evolutionarily conserved throughout Eukarya. Fos proteins characteristically have a leucine zipper and a basic region with a helix-turn-helix motif that binds DNA. In vertebrates, there are several Fos homologs. They can homo-or hetero-dimerize via the leucine zipper domain. Fos homologs coupled with other transcription factors, like Jun oncoproteins, constitute the Activator Protein 1 (AP-1) complex. From its original inception as an oncogene, the subsequent finding that they act as transcription factors binding DNA sequences known as TRE, to the realization that they are activated in many different scenarios, and to loss-offunction analysis, the Fos proteins have traversed a multifarious path in development and physiology. They are instrumental in 'immediate early genes' responses, and activated by a seemingly myriad assemblage of different stimuli. Yet, the majority of these studies were basically gain-of-function studies, since it was thought that Fos genes would be cell lethal. Loss-of-function mutations in vertebrates were recovered later, and were not cell lethal. In fact, c-fos null mutations are viable with developmental defects (osteopetrosis and myeloid lineage abnormalities). It was then hypothesized that vertebrate genomes exhibit partial redundancy, explaining the 'mild' phenotypes, and complicating assessment of complete loss-of-function phenotypes. Due to its promiscuous activation, fos genes (especially c-fos) are now commonly used as markers for cellular responses to stimuli. fos homologs high sequence conservation (including Drosophila) is advantageous as it allows critical assessment of fos genes functions in this genetic model. Drosophila melanogaster contains only one fos homolog, the gene kayak. kayak mutations are lethal, and allow study of all the processes where fos is required. The kayak locus encodes several different isoforms, and is a pleiotropic gene variously required for development involving cell shape changes. In general, fos genes seem to primarily activate programs involved in cellular architectural rearrangements and cell shape changes.
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Introduction: discovery of fos and early studies
At the beginning of the twentieth century several researchers discovered that there were non-cellular "agents" present in tumor tissue that could induce new tumors, when injected to non-infected susceptible organisms, like the Rous avian sarcoma (Rous, 1911) . Later, in many instances, the non-cellular infective agent was found to be of viral origin. One of the first and best known oncogenic viruses is the FinkelBiskis-Jinkins (or FBJ) murine osteosarcoma virus (Finkel et al., 1966a) . This eventually gave rise to the name of the fos gene. The FBJ virus was isolated from an osteosarcoma on the ribs and thoracic spine of one middle-aged mouse fifty years ago (Finkel et al., 1966a (Finkel et al., , 1966b . A filtrate from this tumor was found to cause tumorigenesis in subcutaneously injected mice, mostly osteosarcomas with variable histology (Verma and Graham, 1987) .
Thus, it became paramount for many types of cancers to investigate tumor viral origin. In some instances, tumor tissue produced viral particles that were not capable, on their own, of further infections, but could be paired with "helper" virus to produce new infections (Vogt and Friis, 1971) , strongly suggesting that those viruses had been modified in the course of former infections. The FBJ virus was one such virus (Curran et al., 1983; Curran and Teich, 1982b) . Several years later, when cloning became possible, several genes present in the viral genomes were isolated and found capable of tumorigenicity. They were collectively termed "oncogenes" (Croce, 2008) . They were also found to be the viral, modified counterparts of cellular genes, the first so identified being src (from Rous Sarcoma) (Czernilofsky et al., 1980) . The Fos gene (Finkel-Biskis-Jinkins murine OsteoSarcoma) was originally isolated roughly thirty five years ago as the viral version (v-fos) of the cellular gene c-fos (Curran et al., 1982) , fused to viral sequences of the FBJ virus (Van Beveren et al., 1984; Verma and Graham, 1987) . A second murine transforming version of
